ITRAQ analysis of K562 cell line

ABSTRACT: K562 cells untreated (S) and treated (S+IM) with Imatinib as well as sensitive (S+IM) and resistant (R) to imatinib were subjected to labelled quantification by iTRAQ to identify Bcr-Abl downstream signaling components and proteins modulated in resistance respectively

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Suspension Culture

SUBMITTER: Mythreyi Narasimhan  

LAB HEAD: Dr. Rukmini Govekar

PROVIDER: PXD025173 | Pride | 2021-10-05

REPOSITORIES: Pride